Product Information
CAPRON DMT TABLET is a brand product labeled by Capital Pharma, priced at $0.3276 per EA under NDC 29978012810. Its NADAC has been published 116 times since Jul 17, 2024.
Strength
30; 30 mg/1; mg/1
Manufacturer
Capital PharmaNDC
29978012810
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Effective Date
5/20/2026
Active Ingredients
DEXTROMETHORPHAN HYDROBROMIDE; PYRILAMINE MALEATEApproval Type
Unapproved
On Market Since
1/26/2017
Pharmacological Classes
Price Statistics
The NADAC for CAPRON DMT TABLET has been published 116 times since Jul 17, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3276 per EA |
|---|---|
| All-time high | $0.3300 (Aug 13, 2025) |
| All-time low | $0.3276 (Nov 19, 2025) |
| 52-week high | $0.3287 |
| 52-week low | $0.3276 |
| Median price | $0.3287 |
| Average price | $0.3289 |
| Largest weekly change | -0.4% (Aug 20, 2025) |
| Weeks tracked | 116 |
| Tracking since | Jul 17, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Dextromethorphan HBr and Pyrilamine Maleate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Capital Pharma manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Dextromethorphan HBr and Pyrilamine Maleate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Sigma-1 Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CAPRON DMT TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CAPRON DMT TABLET, manufactured by Capital Pharma, is $0.3276 per EA (NDC 29978012810), effective Sep 30, 2026.
How has the price of CAPRON DMT TABLET changed over time?
Over the history we have for it, the NADAC for CAPRON DMT TABLET has held within roughly two percent of its current level. It has been tracked across 116 weekly CMS publications since Jul 17, 2024.
What are the highest and lowest recorded NADAC prices for CAPRON DMT TABLET?
Since Jul 17, 2024, the NADAC for CAPRON DMT TABLET has ranged from a low of $0.3276 (Nov 19, 2025) to a high of $0.3300 (Aug 13, 2025), with a median of $0.3287 per EA.
Are there cheaper alternatives to CAPRON DMT TABLET?
No other NADAC-published product currently shares the active ingredient and strength of CAPRON DMT TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures CAPRON DMT TABLET?
CAPRON DMT TABLET (NDC 29978012810) is labeled by Capital Pharma, and CMS classifies it as a brand product.